{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:46:57Z","timestamp":1783532817098,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson & Johnson","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12325-025-03219-2","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T03:20:52Z","timestamp":1749612052000},"page":"3826-3838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comorbid Depression and Anxiety Risk in Older Individuals with Geographic Atrophy: A\u00a0US Claims Data Analysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Lisa J.","family":"Faia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ackert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyshah","family":"Abdul Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Garey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Teneralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"6","key":"3219_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMcp2102061","volume":"385","author":"RS Apte","year":"2021","unstructured":"Apte RS. Age-related macular degeneration. N Engl J Med. 2021;385(6):539\u201347.","journal-title":"N Engl J Med"},{"key":"3219_CR2","unstructured":"Centers for Disease Control and Prevention. About common eye disorders and diseases. https:\/\/www.cdc.gov\/vision-health\/about-eye-disorders. Accessed 3 Jan 2025."},{"issue":"3","key":"3219_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","volume":"125","author":"M Fleckenstein","year":"2018","unstructured":"Fleckenstein M, Mitchell P, Freund KB, et al. The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125(3):369\u201390.","journal-title":"Ophthalmology"},{"issue":"5","key":"3219_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","volume":"37","author":"DS Boyer","year":"2017","unstructured":"Boyer DS, Schmidt-Erfurth U, van Lookeren CM, Henry EC, Brittain C. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017;37(5):819\u201335.","journal-title":"Retina"},{"issue":"12","key":"3219_CR5","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","volume":"125","author":"TD Keenan","year":"2018","unstructured":"Keenan TD, Agron E, Domalpally A, et al. Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16. Ophthalmology. 2018;125(12):1913\u201328.","journal-title":"Ophthalmology"},{"issue":"10","key":"3219_CR6","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.ophtha.2013.03.029","volume":"120","author":"N Joachim","year":"2013","unstructured":"Joachim N, Mitchell P, Kifley A, Rochtchina E, Hong T, Wang JJ. Incidence and progression of geographic atrophy: observations from a population-based cohort. Ophthalmology. 2013;120(10):2042\u201350.","journal-title":"Ophthalmology"},{"issue":"9","key":"3219_CR7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/archophthalmol.2009.198","volume":"127","author":"AS Lindblad","year":"2009","unstructured":"Lindblad AS, Lloyd PC, Clemons TE, et al. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol. 2009;127(9):1168\u201374.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"3219_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40123-022-00583-y","volume":"12","author":"T Leng","year":"2023","unstructured":"Leng T, Schwartz J, Nimke D, et al. Dry age-related macular degeneration: distribution of visual acuity and progression risk in a large registry. Ophthalmol Ther. 2023;12(1):325\u201340.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"3219_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajo.2015.04.003","volume":"160","author":"AR Rudnicka","year":"2015","unstructured":"Rudnicka AR, Kapetanakis VV, Jarrar Z, et al. Incidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysis. Am J Ophthalmol. 2015;160(1):85\u201393.e3.","journal-title":"Am J Ophthalmol"},{"key":"3219_CR10","unstructured":"American Macular Disease Foundation. Geographic atrophy. https:\/\/www.macular.org\/about-macular-degeneration\/geographic-atrophy. Accessed 3 Jan 2025."},{"key":"3219_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/OPTH.S226425","volume":"14","author":"PJ Patel","year":"2020","unstructured":"Patel PJ, Ziemssen F, Ng E, et al. Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use. Clin Ophthalmol. 2020;14:15\u201328.","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"3219_CR12","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","volume":"125","author":"U Chakravarthy","year":"2018","unstructured":"Chakravarthy U, Bailey CC, Johnston RL, et al. Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125(6):842\u20139.","journal-title":"Ophthalmology"},{"key":"3219_CR13","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.2147\/OPTH.S455984","volume":"18","author":"SJ Bakri","year":"2024","unstructured":"Bakri SJ, Amoaku WMK, Altman D, et al. The MOSAIC study: a mixed-methods study of the clinical, emotional, and financial burden of geographic atrophy among patients and caregivers in the US. Clin Ophthalmol. 2024;18:2357\u201368.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"3219_CR14","first-page":"1181","volume":"12","author":"A Morga","year":"2023","unstructured":"Morga A, Chamberlain CX, Meyers O, Roberts C, Gaspar L, Su J. Content validity and cognitive debriefing of a patient-reported outcome instrument evaluating symptoms and disease impact in patients with geographic atrophy. Ophthalmol Ther. 2023;12(2):1181\u201393.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"3219_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40123-019-0160-3","volume":"8","author":"S Sivaprasad","year":"2019","unstructured":"Sivaprasad S, Tschosik EA, Guymer RH, et al. Living with geographic atrophy: an ethnographic study. Ophthalmol Ther. 2019;8(1):115\u201324.","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"3219_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jamaophthalmol.2013.2597","volume":"131","author":"X Zhang","year":"2013","unstructured":"Zhang X, Bullard KM, Cotch MF, et al. Association between depression and functional vision loss in persons 20\u00a0years of age or older in the United States, NHANES 2005\u20132008. JAMA Ophthalmol. 2013;131(5):573\u201381.","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"3219_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1167\/iovs.61.5.63","volume":"61","author":"SH Kunzel","year":"2020","unstructured":"Kunzel SH, Moller PT, Lindner M, et al. Determinants of quality of life in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci. 2020;61(5):63.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3219_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12886-023-02901-9","volume":"23","author":"DL Holm","year":"2023","unstructured":"Holm DL, Nielsen MK, Hojsted BB, Sorensen TL. Vision-related quality of life is selectively affected by comorbidities in patients with geographic atrophy. BMC Ophthalmol. 2023;23(1):153.","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"3219_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1167\/iovs.14-15848","volume":"56","author":"HPA van der Aa","year":"2015","unstructured":"van der Aa HPA, Comijs HC, Penninx BW, van Rens GH, van Nispen RM. Major depressive and anxiety disorders in visually impaired older adults. Invest Ophthalmol Vis Sci. 2015;56(2):849\u201354.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3219_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/1120672120901701","volume":"31","author":"EL Mayro","year":"2021","unstructured":"Mayro EL, Murchison AP, Hark LA, et al. Prevalence of depressive symptoms and associated factors in an urban, ophthalmic population. Eur J Ophthalmol. 2021;31(2):740\u20137.","journal-title":"Eur J Ophthalmol"},{"key":"3219_CR21","unstructured":"IQVIA. Support your clinical and economic value proposition with real world data - part 2 in a series. https:\/\/www.iqvia.com\/locations\/united-states\/blogs\/2021\/03\/support-clinical-economic-value-prop-with-rwd-part-2. Accessed 4 Apr 2025."},{"key":"3219_CR22","unstructured":"Merative. Merative MarketScan Research Databases. https:\/\/www.merative.com\/documents\/merative-marketscan-research-databases. Accessed 4 Apr 2025."},{"key":"3219_CR23","unstructured":"Optum. Understand costs and utilization with tried-and-true data. https:\/\/business.optum.com\/en\/data-analytics\/life-sciences\/real-world-data\/claims-data.html. Accessed 4 Apr 2025."},{"issue":"5","key":"3219_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ejvs.2018.06.001","volume":"56","author":"CA Behrendt","year":"2018","unstructured":"Behrendt CA, Debus ES, Mani K, Sedrakyan A. The strengths and limitations of claims based research in countries with fee for service reimbursement. Eur J Vasc Endovasc Surg. 2018;56(5):615\u20136.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"3219_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.36469\/jheor.2023.87538","volume":"10","author":"O Baser","year":"2023","unstructured":"Baser O, Samayoa G, Yapar N, Baser E, Mete F. Use of open claims vs closed claims in health outcomes research. J Health Econ Outcomes Res. 2023;10(2):44\u201352.","journal-title":"J Health Econ Outcomes Res"},{"issue":"4","key":"3219_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/20476965.2019.1581433","volume":"9","author":"R Konrad","year":"2019","unstructured":"Konrad R, Zhang W, Bjarndottir M, Proano R. Key considerations when using health insurance claims data in advanced data analyses: an experience report. Health Syst (Basingstoke). 2019;9(4):317\u201325.","journal-title":"Health Syst (Basingstoke)"},{"key":"3219_CR27","unstructured":"Health Data Management. Harnessing clinical data to surpass the limits of claims information. https:\/\/www.healthdatamanagement.com\/articles\/harnessing-clinical-data-to-surpass-the-limits-of-claims-information?id=133508. Accessed 4 Apr 2025."},{"key":"3219_CR28","unstructured":"Optum. Help clarify market dynamics and uncover insights with claims data. https:\/\/business.optum.com\/content\/dam\/noindex-resources\/business\/pdfs\/sell-sheets\/ols-cdm-sellsheet.pdf. Accessed 4 Apr 2025."},{"key":"3219_CR29","unstructured":"Centers for Disease Control and Prevention. About older adult fall prevention. https:\/\/www.cdc.gov\/falls\/about\/. Accessed 3 Jan 2025."},{"key":"3219_CR30","unstructured":"Snaith RP, Zigmond AS. Hospital Anxiety and Depression Scale (HADS). https:\/\/eprovide.mapi-trust.org\/instruments\/hospital-anxiety-and-depression-scale. Accessed 4 Apr 2025."},{"issue":"4","key":"3219_CR31","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1167\/iovs.06-0761","volume":"48","author":"A Augustin","year":"2007","unstructured":"Augustin A, Sahel JA, Bandello F, et al. Anxiety and depression prevalence rates in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48(4):1498\u2013503.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3219_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1167\/iovs.06-0283","volume":"48","author":"F Bandello","year":"2007","unstructured":"Bandello F, Lafuma A, Berdeaux G. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity. Invest Ophthalmol Vis Sci. 2007;48(1):96\u2013103.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3219_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","volume":"121","author":"FG Holz","year":"2014","unstructured":"Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren CM. Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014;121(5):1079\u201391.","journal-title":"Ophthalmology"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03219-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:07:04Z","timestamp":1757185624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03219-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3219"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03219-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lisa J. Faia received consulting fees from Janssen and participated in speakers\u2019 bureaus for AbbVie\/Allergan, Genentech\/Roche, Alimera, EyePoint, and Astellas. Jessica Ackert is a former employee of Johnson & Johnson and is currently an employee of Sanofi. Rachelle Rodriguez is a former employee of Johnson & Johnson and is currently an employee of Star Epidemiology LLC. Alyshah Abdul Sultan is a former employee of Johnson & Johnson and is currently an employee of Sanofi. Colleen Garey is an employee of Panalgo, which received funding for this analysis from Johnson & Johnson. Rachel E. Teneralli is an employee of Johnson & Johnson. Rose Ong is an employee of Actelion Pharmaceuticals, Ltd., a Johnson & Johnson Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was based on de-identified data collected from three US health care claims databases and did not include human participants; as such, this analysis was exempt from institutional review board oversight and informed consent was not required or obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}